Page 51 - CIBEREHD-2015-eng

Research Groups
Most relevant scientific articles
munoz-Garrido P., marin J.J.G., PeruGorria m.J., ur- riBarri a.d., eriCe o., saez e. eT al. Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental mod- els of polycystic liver disease. Journal of Hepatology. 2015;63(4):952-961.
BarBier-Torres l, Beraza n, fernández-Tussy P, lo- PiTz-oTsoa f, fernández-ramos d, zuBieTe-franCo i eT al. Histone Deacetylase 4 promotes cholestatic liver in- jury in the absence of Prohibitin-1.Hepatology (Baltimore,
CasTilleJo a., hernández-illan e., rodríGuez-soler m., Pérez-CarBonell l., eGoaVil C., BarBera V.m. eT al. Prev- alence of MLH1 constitutional epimutations as a cause of Lynch syndrome in unselected versus selected consecu- tive series of patients with colorectal cancer. Journal of Medical Genetics. 2015;52(7):498-502.
CalVeTe o., reyes J., zuniGa s., Paumard-hernández B., fernández V., BuJanda l. eT al. Exome sequencing iden- tifies ATP4A gene as responsible of an atypical familial
Md.). 2015.
CarBallal s., rodríGuez-alCalde d., moreira l., hernández l., rodríGuez l., rodríGuez-moranTa f. eT al. Colorectal cancer risk factors in patients with serrated polyposis syndrome: A large multicentre study. Gut. 2015.
Highlights
During the year 2015 have started new projects re- lated to colon cancer (EPOs-Qualyscopia) attempt- ing to assess the most appropriate follow-up in patients who have polyps and the quality of colonos- copy. We have also been getting results from other started in previous years as the study of biomarkers in colon cancer in different biological fluids. On this year we have created along with 15 research groups from 10 European countries “European Network for the Study of Cholangiocarcinoma” (ENS-CCA:
type I gastricneuroendocrine tumour. Human Molecular Genetics. 2015;24(10):2914-2922.
www.enscca.org ; www.cholangiocarcinoma.eu) to promote international collaborative research this disease; Dr. Jesus Bañales is the International Net- work Coordinator. In addition, we got the competi- tive public financing of a project FIS cholangiocar- cinoma (CCA), a collaborative project of excellence (CIBEREHD), two projects of the Basque Govern- ment (Polycystic Liver Disease) and a project of the Council of Gipuzkoa on Polycystic Liver disease.
Institution: Asociación Instituto Biodonostia · Contact: Hospital Donostia · Paseo Dr. Beguiristain, s/n. 20014 San Sebastián · Tel.: 659 781 746 · E.mail: [email protected]
Website: https://intranet.cientifis.com/CiberEHD/intranet/
CIBEREHD I Annual report 2015 I 51